{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:04:01Z","timestamp":1790021041506,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jiac.2025.102721","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:09:35Z","timestamp":1745867375000},"page":"102721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inpatient burden of COVID-19 in Japan: A retrospective cohort study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-800X","authenticated-orcid":false,"given":"Kathleen M.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3893-9176","authenticated-orcid":false,"given":"Kosuke","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6598-2744","authenticated-orcid":false,"given":"Benjamin T.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9235-6850","authenticated-orcid":false,"given":"Matthew T.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-5395","authenticated-orcid":false,"given":"Verna","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102721_bib1","unstructured":"Visualizing the data: information on COVID-19 infections [Internet]. [cited 2024 Mar 13]. Available from:. https:\/\/covid19.mhlw.go.jp\/en\/."},{"issue":"2","key":"10.1016\/j.jiac.2025.102721_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.35772\/ghm.2023.01023","article-title":"An overview of the reclassification of COVID-19 of the infectious diseases Control Law in Japan","volume":"5","author":"Kitahara","year":"2023","journal-title":"Glob Health Med"},{"key":"10.1016\/j.jiac.2025.102721_bib3","unstructured":"Novel Coronavirus (COVID-19) [Internet]. [cited 2024 Mar 13]. Available from:.https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000164708_00079.html."},{"key":"10.1016\/j.jiac.2025.102721_bib4","unstructured":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) | Br Med J [Internet]. [cited 2024 Feb 7]. Available from: https:\/\/www.bmj.com\/content\/363\/bmj.k3532.full."},{"issue":"1","key":"10.1016\/j.jiac.2025.102721_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5680","article-title":"Inventory of real-world data sources in Japan: annual survey conducted by the Japanese society for pharmacoepidemiology task force","volume":"33","author":"Kumamaru","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jiac.2025.102721_bib6","unstructured":"MDV Database Overview | MDV EBM insight [Internet]. [cited 2024 Feb 29]. Available from: https:\/\/en.mdv.co.jp\/ebm\/about-mdv-database\/mdv-database-overview\/."},{"issue":"3","key":"10.1016\/j.jiac.2025.102721_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/INF.0000000000004181","article-title":"Clinical practice patterns and risk factors for severe conditions in pediatric hospitalizations with respiratory syncytial virus in Japan: a nationwide analyses (2018-2022)","volume":"43","author":"Okubo","year":"2024","journal-title":"Pediatr Infect Dis J"},{"issue":"29","key":"10.1016\/j.jiac.2025.102721_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011491","article-title":"Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus: a structural equation modeling approach","volume":"97","author":"Sruamsiri","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.jiac.2025.102721_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ped.14957","article-title":"Epidemiology of respiratory syncytial virus in Japan: a nationwide claims database analysis","volume":"64","author":"Kobayashi","year":"2022","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.jiac.2025.102721_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-018-0268-8","article-title":"Burden of herpes zoster in the Japanese population with immunocompromised\/chronic disease conditions: results from a cohort study claims database from 2005\u20132014","volume":"9","author":"Imafuku","year":"2018","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jiac.2025.102721_bib12","article-title":"Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: a population-based, matched cohort study","volume":"18","year":"2023","journal-title":"PLoS One"},{"issue":"10332","key":"10.1016\/j.jiac.2025.102721_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jiac.2025.102721_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmicom.2024.100005","article-title":"Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center","volume":"1","author":"Orel","year":"2024","journal-title":"CMI Commun"},{"issue":"3","key":"10.1016\/j.jiac.2025.102721_bib15","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/ijerph20032150","article-title":"Outcomes of elderly patients hospitalized with the SARS-CoV-2 omicron B.1.1.529 variant: a systematic review","volume":"20","author":"Fericean","year":"2023","journal-title":"Int J Environ Res Publ Health"},{"issue":"1","key":"10.1016\/j.jiac.2025.102721_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.35772\/ghmo.2023.01025","article-title":"Difference in clinical courses and causes of COVID-19-related deaths in hospitalized patients infected with omicron and delta variants: a retrospective study in Japan","volume":"4","author":"Sakurai","year":"2024","journal-title":"GHM Open"},{"issue":"43","key":"10.1016\/j.jiac.2025.102721_bib17","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15585\/mmwr.mm7043e1","article-title":"Severity of disease among adults hospitalized with laboratory-confirmed COVID-19 before and during the period of SARS-CoV-2 B.1.617.2 (delta) predominance - COVID-NET, 14 States, january-august 2021","volume":"70","author":"Taylor","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"10.1016\/j.jiac.2025.102721_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15585\/mmwr.mm7023e1","article-title":"Hospitalization of adolescents aged 12-17 Years with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-april 24, 2021","volume":"70","author":"Havers","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.jiac.2025.102721_bib19","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1093\/cid\/ciaa1012","article-title":"Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-Associated hospitalization surveillance network (COVID-NET)","volume":"72","author":"Kim","year":"2021","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"40","key":"10.1016\/j.jiac.2025.102721_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.15585\/mmwr.mm7240a3","article-title":"COVID-19-Associated hospitalizations among U.S. Adults aged \u226565 Years - COVID-NET, 13 States, January-August 2023","volume":"72","author":"Taylor","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.jiac.2025.102721_bib21","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/ciaa1806","article-title":"Characteristics of adults aged 18-49 Years without underlying conditions hospitalized with laboratory-confirmed coronavirus disease 2019 in the United States: COVID-NET-March-August 2020","volume":"72","author":"Owusu","year":"2021","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"32","key":"10.1016\/j.jiac.2025.102721_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.15585\/mmwr.mm6932e3","article-title":"Hospitalization rates and characteristics of children aged <18 Years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020","volume":"69","author":"Kim","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2025.102721_bib23","article-title":"Comparison of influenza and COVID-19\u2013associated hospitalizations among children < 18 years old in the United States\u2014FluSurv-NET (October\u2013April 2017\u20132021) and COVID-NET (October 2020\u2013September 2021)","author":"Delahoy","year":"2022","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"16","key":"10.1016\/j.jiac.2025.102721_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.15585\/mmwr.mm7116e1","article-title":"Hospitalizations of children aged 5-11 Years with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022","volume":"71","author":"Shi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.jiac.2025.102721_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.15585\/mmwr.mm7107e4","article-title":"Hospitalizations of children and Adolescents with laboratory-confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022","volume":"71","author":"Marks","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2025.102721_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1261046","article-title":"Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US","volume":"11","author":"McGrath","year":"2023","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.jiac.2025.102721_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246318","article-title":"COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis","volume":"16","author":"Chang","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jiac.2025.102721_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.30773\/pi.2021.0220","article-title":"A comparative study of social impacts of the COVID-19 pandemic on Republic of Korea, Japan, and Taiwan","volume":"18","author":"Lo","year":"2021","journal-title":"Psychiatry Investig"},{"issue":"1","key":"10.1016\/j.jiac.2025.102721_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14760584.2024.2323133","article-title":"Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan","volume":"23","author":"Nagano","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jiac.2025.102721_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvp.2023.102007","article-title":"The effects of secondary stressors, social identity, and social support on perceived stress and resilience: findings from the COVID-19 pandemic","volume":"88","author":"Ntontis","year":"2023","journal-title":"J Environ Psychol"},{"issue":"1","key":"10.1016\/j.jiac.2025.102721_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/14760584.2023.2157817","article-title":"Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data","volume":"22","author":"Yang","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.jiac.2025.102721_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jiac.2024.02.026","article-title":"Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period","volume":"30","author":"Murakami","year":"2024","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T03:03:07Z","timestamp":1749697387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1341321X25001187"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102721","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.28.24309640","asserted-by":"object"}]},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient burden of COVID-19 in Japan: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102721"}}